Pursuing Innovation in Expanded Access to Prescription Therapeutics

ABOUT US

Aiming for access without the need for a physician and prescription

Petros Pharmaceuticals is committed to the goal of becoming a leading innovator in the emerging self-care market driving expanded access to key prescription pharmaceuticals as Over-the-Counter treatment options.

Currently, Petros is pursuing increased access for its flagship prescription ED therapy via potential OTC designation. 

If ultimately approved by the FDA for OTC access, this therapy may be the first in its class to achieve this marketing status, also establishing company know how as a proven platform for the development of further prospective prescription therapeutics.

expert LEADERSHIP

Management Team

The Petros leadership team hosts extensive experience in the bio-pharmaceutical industry with experience in successful clinical development programs, regulatory approvals, commercial launches and enduring market-leading innovations. 

Fady Boctor

President, Chief Commercial Officer

Mitch Arnold

VP of Finance, Chief Accounting Officer

Robert Weinstein

Interim Chief Financial Officer

Board of Directors

John Shulman

Executive Chairman of the Board

Josh Silverman

Vice-Chairman of the Board

Greg Bradley

Board of Directors

Wayne Walker

Board of Directors

Bruce Bernstein

Board of Directors

Enhancing consumer reach to medications via the development of over-the-counter (OTC) drug programs.